PATENT CLAIM ANALYSIS

Application Number: 15935739
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "464000"]

Abstract:
The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Claim (Index 54):
The pharmaceutical composition of  claim 48 , comprising up to about 1 g of dihomo gamma linolenic acid and wherein the composition comprises not more than 5%, by weight of total fatty acids, of any individual fatty acid other than dihomo gamma linolenic acid.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.13636
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14730818', '15661374', '14307195', '15898148', '15898143']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6956752430641349
- 35 USC 102 Novelty (BERT): 0.5587504042029487
- Combined Prediction Score: 0.6819827591780163
- Mean Citation Score: 317.293044
- Max Citation Score: 448.53607
- Similarity Product: 346.46552491385336

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test